[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
February 23, 2000

Estrogen and Alzheimer DiseasePlausible Theory, Negative Clinical Trial

Author Affiliations

Author Affiliations: National Institute of Child Health and Human Development–Yale Center for the Study of Learning and Attention, Department of Pediatrics, Yale University School of Medicine, New Haven, Conn.

JAMA. 2000;283(8):1055-1056. doi:10.1001/jama.283.8.1055

Whether to use estrogen replacement therapy in postmenopausal women continues to represent a major concern for women and their physicians. In the last few years, it has become clear that estrogen exerts a wide range of effects, including (in addition to its effects on reproduction) effects on the cardiovascular system,1 skeletal system2 and, of particular interest, neuronal systems serving cognitive function, especially memory.37

First Page Preview View Large
First page PDF preview
First page PDF preview
×